Xu H - Search Results

1

Screening of potential biomarkers for chemoresistant ovarian carcinoma with miRNA expression profiling data by bioinformatics approach.

Wei S, Wang Y, Xu H, Kuang Y. Wei S, et al. Among authors: xu h. Oncol Lett. 2015 Oct;10(4):2427-2431. doi: 10.3892/ol.2015.3610. Epub 2015 Aug 14. Oncol Lett. 2015. PMID: 26622864 Free PMC article.

2

Inhibition of enhancer of zeste homolog 2 increases the expression of p16 and suppresses the proliferation and migration of ovarian carcinoma cells in vitro and in vivo.

Lu F, Xu H, Wang Q, Li M, Meng J, Kuang Y. Lu F, et al. Among authors: xu h. Oncol Lett. 2018 Mar;15(3):3233-3239. doi: 10.3892/ol.2017.7712. Epub 2017 Dec 28. Oncol Lett. 2018. PMID: 29435063 Free PMC article.

3

Systematic enrichment analysis of microRNA expression profiling studies in endometriosis.

Wei S, Xu H, Kuang Y. Wei S, et al. Among authors: xu h. Iran J Basic Med Sci. 2015 May;18(5):423-9. Iran J Basic Med Sci. 2015. PMID: 26124927 Free PMC article. Review.

4

miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.

He Z, Xu H, Meng Y, Kuang Y. He Z, et al. Among authors: xu h. Biomed Pharmacother. 2017 Apr;88:902-910. doi: 10.1016/j.biopha.2017.01.117. Epub 2017 Feb 6. Biomed Pharmacother. 2017. PMID: 28178620

5

Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo.

Kuang Y, Lu F, Guo J, Xu H, Wang Q, Xu C, Zeng L, Yi S. Kuang Y, et al. Among authors: xu c, xu h. Onco Targets Ther. 2017 Jun 26;10:3131-3144. doi: 10.2147/OTT.S134784. eCollection 2017. Onco Targets Ther. 2017. PMID: 28706445 Free PMC article.

6

Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer.

Kuang Y, Xu H, Lu F, Meng J, Yi Y, Yang H, Hou H, Wei H, Su S. Kuang Y, et al. Among authors: xu h. Cancer Sci. 2021 Jan;112(1):231-242. doi: 10.1111/cas.14708. Epub 2020 Nov 21. Cancer Sci. 2021. PMID: 33091189 Free PMC article.

7

Reduced expression and prognostic implication of inhibitor of growth 4 in human osteosarcoma.

Zhao D, Liu X, Zhang Y, Ding Z, Dong F, Xu H, Wang B, Wang W. Zhao D, et al. Among authors: xu h. Oncol Lett. 2016 Apr;11(4):2869-2874. doi: 10.3892/ol.2016.4324. Epub 2016 Mar 9. Oncol Lett. 2016. PMID: 27073567 Free PMC article.

8

B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer.

Xu H, Chen X, Tao M, Chen K, Chen C, Xu G, Li W, Yuan S, Mao Y. Xu H, et al. Among authors: xu g. Oncol Lett. 2016 Mar;11(3):1841-1846. doi: 10.3892/ol.2016.4128. Epub 2016 Jan 19. Oncol Lett. 2016. PMID: 26998087 Free PMC article.

9

TIPE2 functions as a metastasis suppressor via negatively regulating β-catenin through activating GSK3β in gastric cancer.

Wu J, Zhang H, Xu C, Xu H, Zhou X, Xie Y, Tao M. Wu J, et al. Among authors: xu c, xu h. Int J Oncol. 2016 Jan;48(1):199-206. doi: 10.3892/ijo.2015.3224. Epub 2015 Oct 30. Int J Oncol. 2016. PMID: 26530498

10

Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer.

Wu J, Zhu Y, Xu C, Xu H, Zhou X, Yang J, Xie Y, Tao M. Wu J, et al. Among authors: xu c, xu h. Oncol Rep. 2016 Jan;35(1):243-52. doi: 10.3892/or.2015.4385. Epub 2015 Nov 3. Oncol Rep. 2016. PMID: 26530780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,400 results

Search Page

Filters